This may be the year we see retail roar back. If you remove the last quarter of 2018, the sector posted strong performance numbers. Surging behind low unemployment, climbing consumer confidence, and a better-than-expected holiday season, retail hit fresh highs in 2018. Then, along with the rest of the market, the bottom fell out in December with stocks plunging to their worse end-of-year performance since the Great Depression. —Recommended Link— Wall Street Won’t Tell You About This… But We Just Uncovered A Bombshell… I’ve created an in-depth report for this opportunity and it covers what I believe is the… Read More

This may be the year we see retail roar back. If you remove the last quarter of 2018, the sector posted strong performance numbers. Surging behind low unemployment, climbing consumer confidence, and a better-than-expected holiday season, retail hit fresh highs in 2018. Then, along with the rest of the market, the bottom fell out in December with stocks plunging to their worse end-of-year performance since the Great Depression. —Recommended Link— Wall Street Won’t Tell You About This… But We Just Uncovered A Bombshell… I’ve created an in-depth report for this opportunity and it covers what I believe is the biggest investment opportunity we’ll see in our lifetime… It will change the concept of what it means to be human, as we see major diseases eradicated… and as our life expectancy reaches 120 years. I’ve been tracking this development for seven years… At the same time, consumer confidence remains high, oil prices low, and employment solid in the face of the retail rout. Add in the abating Chinese tariff pressures and a bullish picture is painted for retail and the overall market in 2019. #-ad_banner-#Strategically buying dips is a time-honored way to profit from the stock market. December beat retail… Read More

The next week will be an interesting week in the stock market. Of course, there’s never any shortage of events that could change the outlook for the market one way or another… But according to a chart of the S&P 500, it looks like we’re at an important technical resistance level. Resistance is an important technical term for a price level where a security’s advance is expected to stall. In other words, it’s a price level where sellers appear, and their actions can often be anticipated. In the chart below, I’ve labeled three factors that are all pointing toward resistance… Read More

The next week will be an interesting week in the stock market. Of course, there’s never any shortage of events that could change the outlook for the market one way or another… But according to a chart of the S&P 500, it looks like we’re at an important technical resistance level. Resistance is an important technical term for a price level where a security’s advance is expected to stall. In other words, it’s a price level where sellers appear, and their actions can often be anticipated. In the chart below, I’ve labeled three factors that are all pointing toward resistance near the S&P 500’s current level around 2,600… 1. The March lows (blue dashed line): Many investors like to buy stocks when they approach previous lows, as it often represents a “safe” bargain price. We saw this in action back in October and November, when stocks fell to their March lows (which then represented “support”) and were met with aggressive buying. However, stocks suffered a rapid loss in December, so anyone who bought at last year’s lows is just getting back to even. From what I’ve observed, many traders tend to sell the moment their positions get back… Read More

Money and health… As the calendar flips over to a new year, these two areas of our lives tend to become a focal point for improvement. On the money side of things, we assess our financial house and set goals (read resolutions) to pay down debt, save more, increase income, and reevaluate our retirement strategy. —Recommended Link— How To Play The Government Shutdown For Maximum Portfolio Gain Since the government has shut its doors, the market has already soared 10%. Here’s the best trade to profit from it over the next week. Read More

Money and health… As the calendar flips over to a new year, these two areas of our lives tend to become a focal point for improvement. On the money side of things, we assess our financial house and set goals (read resolutions) to pay down debt, save more, increase income, and reevaluate our retirement strategy. —Recommended Link— How To Play The Government Shutdown For Maximum Portfolio Gain Since the government has shut its doors, the market has already soared 10%. Here’s the best trade to profit from it over the next week. Click here. On the health side of the equation, we want to lose weight, eat healthier, and build muscle. Gym memberships typically skyrocket this time of year, diet books are sold out, and health-monitoring devices fly off the shelves.  It’s no surprise that these are the two areas that receive the most attention. After all, household debt totaled $13.5 trillion at the end of last year’s third quarter — an all-time high. When looking only at credit card debt, student, auto, and personal loans, that figure stood at nearly $4 trillion, surpassing the previous high-water mark set in the… Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this year, nearly four-fold the return on the S&P 500, after having crashed 11.8% last year. Valuation multiples are down and acquisition activity for 2019 is already 26% of last year’s total. —Recommended Link— How To Make Massive Gains When The Market Tumbles Industry veteran invites 50 investors to join him in the world’s only legal market hack that actually works… discover how to bring home an… Read More

After finishing 2018 as one of the worst-performing sectors, it looks like biotech could be a runaway leader this year. The iShares Nasdaq Biotechnology ETF (Nasdaq: IBB) has surged 13% so far this year, nearly four-fold the return on the S&P 500, after having crashed 11.8% last year. Valuation multiples are down and acquisition activity for 2019 is already 26% of last year’s total. —Recommended Link— How To Make Massive Gains When The Market Tumbles Industry veteran invites 50 investors to join him in the world’s only legal market hack that actually works… discover how to bring home an extra $37,000 in the next 365 days or less. Biotech is one of the few industries that should remain relatively immune from worries over the trade war and could be a bright spot in an otherwise volatile year. #-ad_banner-#In perhaps no other industry is stock-picking more important than in biotech. Investor sentiment could boost the entire group, but it will be the individual companies with breakthrough drugs that will provide outsized returns. Get Ready For The 2019 Biotech Boom The market was largely disappointed in biotech acquisitions last year and investors reflected their dissatisfaction in share prices. Passage of… Read More

I’m starting the New Year by reading some of the classics to develop a deeper understanding of some investment concepts. Among the concepts I’m researching… is the Keynesian beauty contest. Economist John Maynard Keynes used the “beauty contest” to explain why stock prices move up and down. —Recommended Link— Radical New Accelerated Dividend Program Lets YOU Pick When To Get Paid Attention Income Investors: That’s right, you pick your own “ex-dividend” date. I’ve already collected $119,247 In “Bonus Dividends” this way… on top of my regular dividends. While Keynes is deservedly… Read More

I’m starting the New Year by reading some of the classics to develop a deeper understanding of some investment concepts. Among the concepts I’m researching… is the Keynesian beauty contest. Economist John Maynard Keynes used the “beauty contest” to explain why stock prices move up and down. —Recommended Link— Radical New Accelerated Dividend Program Lets YOU Pick When To Get Paid Attention Income Investors: That’s right, you pick your own “ex-dividend” date. I’ve already collected $119,247 In “Bonus Dividends” this way… on top of my regular dividends. While Keynes is deservedly recognized for his economic insights, he was also a great investor. From 1924 to 1946, he managed a fund for King’s College from 1924 to 1946. Over that time, the benchmark stock market index in Great Britain declined 15% as the Great Depression and World War II weighed on the market. Keynes delivered a total return of more than 1,160% during that time, an average annual return of about 12% a year. #-ad_banner-#To explain how he thought about the stock market, Keynes compared investors to readers of a newspaper that sponsored a beauty contest. (This book was published in 1936,… Read More

Dear Mr. Culp, I wish you the best in your new challenge. This Motley Fool article about your background is encouraging. Why am I writing this? During the Jack Welch era, GE contracted with my training company, Value Selling. GE’s needs were different. Jack’s vision was clear. Each business was required to grow market share and improve their profit margins – even if they sold commodity products. —Recommended Link— Looking For Bigger Gains? Want To Reduce Your Risk? For a limited time only, discover how one industry veteran is generating 37,000 or more in additional income… Read More

Dear Mr. Culp, I wish you the best in your new challenge. This Motley Fool article about your background is encouraging. Why am I writing this? During the Jack Welch era, GE contracted with my training company, Value Selling. GE’s needs were different. Jack’s vision was clear. Each business was required to grow market share and improve their profit margins – even if they sold commodity products. —Recommended Link— Looking For Bigger Gains? Want To Reduce Your Risk? For a limited time only, discover how one industry veteran is generating 37,000 or more in additional income with no added risk. Newly disclosed details here. Professor Noel Tichy defined corporate culture as – “The unwritten norms, beliefs and values that define appropriate behavior.” Our challenge was to assist with changing the culture of the sales force from order takers to consultants; part of the inner circle of profit improvers for their major customers. #-ad_banner-#Several clients funded a research project. I researched their top salespeople. What did these elite performers do that set them apart? I was amazed; it made little difference whether they sold high tech products or commodities, or where they fit in the distribution channel,… Read More

The nine-year streak has ended. 2018 marks the first time since 2008 that the S&P 500 closed in the red. The index lost 6.3%, not including dividends. With dividends accounted for, the loss was 4.4%. —Recommended Link— Make Money Every Time You Trade Over the past year, I placed 49 trades… and had 49 winners. Here’s my secret… “This is the first time I have had a ‘strategy’ and a system to generate consistent and regular income,” says subscriber, Dennis J. Keep reading… December alone saw its worst performance since… Read More

The nine-year streak has ended. 2018 marks the first time since 2008 that the S&P 500 closed in the red. The index lost 6.3%, not including dividends. With dividends accounted for, the loss was 4.4%. —Recommended Link— Make Money Every Time You Trade Over the past year, I placed 49 trades… and had 49 winners. Here’s my secret… “This is the first time I have had a ‘strategy’ and a system to generate consistent and regular income,” says subscriber, Dennis J. Keep reading… December alone saw its worst performance since the Great Depression — the S&P 500 ended with a 9.2% loss. And while the major blue-chip indexes — S&P 500 and Dow Jones Industrial Average — have yet to enter official bear-market territory, the same can’t be true for other indexes. The Wilshire 5000 dropped below the 20% bear-market threshold in December, as did the Nasdaq, Russell 2000, and the Dow Jones Transportation Average. Now the question on everybody’s mind is… are we going into a recession? The Important Thing To Remember About Recessions… Here’s the thing about recessions, we don’t know when recessions start, or… Read More

In show business, you’re only as good as your last hit whether it’s a play, movie, or song. Oddly, the pharmaceutical business used to be the same way. As a young pup in the mid ’90s, I remember the veteran brokers loitering around the coffee machine jabbering about pharma stocks and the drugs the companies had in their pipelines. Remember, this was when Pfizer (NYSE: PFE) had just fired the opening salvo in the Baby Boom’s second sexual revolution with its blockbuster erectile dysfunction treatment Viagra. —Recommended Link— Learn How This New Medical Breakthrough Will Wipe Out Cancers, Heart Disease,… Read More

In show business, you’re only as good as your last hit whether it’s a play, movie, or song. Oddly, the pharmaceutical business used to be the same way. As a young pup in the mid ’90s, I remember the veteran brokers loitering around the coffee machine jabbering about pharma stocks and the drugs the companies had in their pipelines. Remember, this was when Pfizer (NYSE: PFE) had just fired the opening salvo in the Baby Boom’s second sexual revolution with its blockbuster erectile dysfunction treatment Viagra. —Recommended Link— Learn How This New Medical Breakthrough Will Wipe Out Cancers, Heart Disease, Alzheimer And Many Other Illnesses Read on and learn how you can make millions. And during the next two days only you will save 75%. However, over the last decade, as the trend of big pharma companies subbing out their research and development (R&D) to smaller, faster moving biotech companies has proliferated, you hear less chatter about Merck (NYSE: MRK) or Johnson & Johnson (NYSE: JNJ) having this or that drug in phase one, two, or three. #-ad_banner-#Then again, maybe I’m hanging out with the wrong people or not watching the right financial news shows. So, I decided to… Read More